"The
Report Active Pharmaceutical Ingredients (APIs) Market in Asia
Pacific to 2017 - Increasing Penetration in China and India Coupled
with Low Cost Manufacturing to Fuel Regional Growth provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
GBI
Research’s report, “Active Pharmaceutical Ingredients (APIs)
Market in Asia Pacific to 2017 Increasing Penetration in China and
India Coupled with Low Cost Manufacturing to Fuel Regional Growth”,
provides a detailed insight into the Asia-Pacific API market. The
research presents detailed analysis and forecasts of the major
economic and market trends affecting the API markets in this region.
The report contains market forecasts, product type analysis, drivers
and restraints. In addition, it includes therapeutic categories
analysis and CMO growth in the region, and its influence on API
manufacturing activity towards 2017. Overall, the report presents a
comprehensive analysis of the Asia-Pacific API market, covering all
of the major parameters. The report is built using data and
information sourced from proprietary databases, primary and secondary
research, and in-house analysis by GBI Research’s team of industry
experts.
Asia-Pacific
is the second largest regional market for APIs by revenue in the
world. The Asia-Pacific active pharmaceutical ingredients market
revenue held a share of around 28.3% of the global API market in
2011, with the global revenue standing at $108,613m. Total revenue
generated by the Asia-Pacific API market was $30,693m in 2011, and is
expected to grow at a CAGR of 5.6% to reach $63.8 billion by 2017.
This will be supported by healthy demand from the biotech and generic
API sectors.
View Report At
:http://www.marketresearchreports.biz/analysis/149597
Scope
- Market revenue data for APIs from 2005 to 2011 and forecasts for six years to 2017.
- API markets in key countries in the region, including Japan, China, South Korea and India.
- API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology for the Asia-Pacific region.
- Drivers of the API market, such as the growth of generic drugs, and restraints.
- Detailed historic and forecast trends and share analysis of API revenue, based on product types (synthetic and biotech APIs) in the Asia-Pacific market, and in key countries of the region.
- d on customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) in the Asia-Pacific market, and in key countries of the region.
- Analysis of API revenue based on therapeutic categories at a regional and key country level.
Reasons to buy
- Develop business strategies with the help of specific insights on the Asia-Pacific API market.
- Identify opportunities and challenges in the Asia-Pacific API market.
- Invest in the growing segments of the API market.
- Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the Asia-Pacific API market.
- Benchmark your operations and strategies against the major players in the global API market.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/149597
Table
of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
3 Contract Manufacturing
Organizations (CMO) 11
3.1 Process of CMO Outsourcing 11
3.2 Asia-Pacific CMO Market
Drivers 12
3.2.1 Availability of Low-cost
Skilled Manpower 12
3.2.2 Key Benefits of Outsourcing
13
3.3 Asia-Pacific CMO Market
Revenues and Forecast to 2017 14
4 Asia-Pacific Active
Pharmaceutical Ingredients Market 16
4.1 Asia-Pacific API Industry
Structure 16
4.2 Asia-Pacific API Distribution
Structure 17
4.3 Asia-Pacific API Market
Overview 18
4.4 Asia-Pacific APIs Market
Segmentation 19
4.4.1 Synthetic APIs 19
4.4.2 Biotech APIs 20
4.5 Asia-Pacific APIs Market
Drivers 20
4.5.1 Growing Pharmaceutical
Manufacturing Capabilities of Developing Countries Such as China and
India are Attracting APIs Manufacturing from Developed Countries 20
4.5.2 Domestic Market Growth of
Developing Countries in Asia-Pacific is Providing Global
Pharmaceutical Industry Growth 20
4.5.3 Increasing Focus on Biotech
API Drugs in Asia-Pacific will Contribute Significantly to
Asia-Pacific APIs Market Growth 20
4.5.4 The Improving Regulatory
Framework in Markets of China and India is Increasing the Penetration
of Branded Drugs 21
4.5.5 Patent Expiries of
Blockbuster Drugs Boosting the Market Revenues in Asia-Pacific 21
4.6 Asia-Pacific APIs Market
Restraints 21
4.6.1 Increasing Patent Expiries
Hamper the Growth of the Branded API Market 21
4.6.2 Highly Fragmented Market
Restricts the Revenue Growth of the Asia-Pacific API Market 21
4.6.3 Limited Improvement in
Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth
Potential 21
4.6.4 High Currency Fluctuations
Hamper the Value Growth of the Pharmaceutical Market in the
Asia-Pacific Region 22
4.7 Asia-Pacific APIs Market
Revenue and Forecasts to 2017 22
4.8 Asia-Pacific Revenue Share
Analysis by Product Types 24
4.9 Asia-Pacific Synthetic APIs
Market 25
4.9.1 Asia-Pacific Synthetic APIs
Market Drivers 25
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment